|
Meningitis, Meningococcal
|
C01.150.252.400.625.549.449 |
|
|
Meningococcal Infections
|
C01.150.252.400.625.549 |
|
|
United States Social Security Administration
|
I01.409.418.750.999 |
|
|
Biota
|
N06.230.124.049.100 |
|
|
United States Occupational Safety and Health Administration
|
I01.409.418.750.992 |
|
|
Vibrio cholerae
|
B03.660.250.830.830.100 |
|
|
Aurora Kinase B
|
D08.811.913.696.620.682.700.103.750 |
|
|
Censorship, Research
|
D000068597 |
[The act or practice of scrutinizing the practice of scientific research for the purpose of preventing or suppressing the unethical applications as well knowledge derived from it.
] |
|
Wiskott-Aldrich Syndrome
|
C16.320.099.970 |
|
|
Data Accuracy
|
D000068598 |
[A measure of scientific precision, exactness, or correctness of quantitative or qualitative values, relative to the actual or true measurements.
] |
|
Brimonidine Tartrate, Timolol Maleate Drug Combination
|
D000068599 |
[A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.
] |
|
Encainide
|
D02.092.146.113.385 |
|
|
Deamino Arginine Vasopressin
|
D12.644.548.691.692.781.100.250 |
|
|
Arginine Vasopressin
|
D12.644.548.691.692.781.100 |
|
|
Receptor-Interacting Protein Serine-Threonine Kinase 2
|
D12.644.360.024.500.186.500 |
|
|
c-Mer Tyrosine Kinase
|
D12.776.624.664.700.037 |
|
|
Wakefulness
|
F02.830.104.821 |
|
|
Elongin
|
D12.776.930.215 |
|
|
Erythroid-Specific DNA-Binding Factors
|
D12.776.930.216 |
|
|
Nifedipine
|
D03.383.725.203.540 |
|
